Related Experiment Video
Updated: Sep 11, 2025
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori Infection in Children Versus Adults, Differences in Management Guidelines: Risks and Benefits of
Matjaž Homan1, Zrinjka Mišak2, Francis Megraud3
1Department of Gastroenterology, Hepatology, and Nutrition, University Children's Hospital, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Insights
Helicobacter pylori management differs between children and adults due to varying clinical presentations and rising antibiotic resistance. Carefully weigh the risks and benefits of treatment, especially in pediatric cases.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Helicobacter pylori infection presents differently in children and adults, impacting natural history, prevalence, and clinical outcomes.
- Antibiotic resistance rates for H. pylori are increasing globally, complicating treatment strategies.
- Existing management guidelines often do not adequately address the unique aspects of H. pylori in pediatric populations.
Purpose of the Study:
- To review the key differences in Helicobacter pylori infection between children and adults.
- To analyze the risks and benefits associated with H. pylori eradication therapy in children.
- To provide a comprehensive overview for clinicians managing H. pylori in pediatric patients.
Main Methods:
- Literature review of studies comparing H. pylori in children and adults.
- Analysis of data on prevalence, clinical manifestations, and antibiotic resistance patterns.
- Evaluation of treatment outcomes, risks, and benefits specific to pediatric populations.
Main Results:
- Significant variations exist in H. pylori epidemiology, clinical presentation, and antibiotic resistance between pediatric and adult patients.
- H. pylori eradication in children carries potential risks, including antibiotic side effects and loss of protective effects against allergies.
- Benefits of eradication include preventing gastric complications and reducing parental anxiety, but treatment success rates may differ.
Conclusions:
- H. pylori management requires distinct approaches for children and adults, necessitating tailored guidelines.
- The decision to treat H. pylori in children must involve a careful risk-benefit assessment.
- Further research is needed to optimize pediatric H. pylori treatment strategies amidst rising antibiotic resistance.
Abstract:
Helicobacter pylori infection in children and adults differs in several aspects such as the natural history, prevalence, the clinical presentations and complications, antibiotic resistance rates, treatment options, and the success rates of treatment. Due to all the abovementioned differences, management guidelines and recommendations are different between children and adults. In parallel to the steady decrease in the rate of H. pylori infection in the Western world in recent years, both in children and adults, antibiotic resistance rates have risen to alarming rates. The risk and benefits of eradication treatment, especially in children, must be considered when deciding "to treat or not." The risks include the negative effects of antibiotics, treatment failure, and reinfection as well as the possibility of losing the "protective effect" of H. pylori on atopy, allergy, and possibly on other gastrointestinal diseases. On the other hand, there are also many benefits of eradication therapy such as prevention of gastric complication and associated non-gastric complications as well as reduction of parental anxiety of nontreatment. This review summarizes the differences related to H. pylori in children versus adults and the risks and benefits of treatment in children.
More Related Videos
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:21Factors Affecting Drug Response: Overview
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.